U.S. Markets open in 4 hrs 50 mins

SPDR S&P Pharmaceuticals ETF (XPH)

NYSEArca - NYSEArca Delayed Price. Currency in USD
Add to watchlist
42.155-0.625 (-1.461%)
At close: 3:59PM EDT
People also watch
IHEPJPXSDXRTXBI
Full screen
Previous Close42.780
Open42.800
Bid39.020 x 100
Ask0.000 x 0
Day's Range42.090 - 42.800
52 Week Range36.580 - 47.100
Volume58,582
Avg. Volume95,126
Net Assets450.55M
NAV42.91
PE Ratio (TTM)N/A
Yield0.61%
YTD Return10.07%
Beta (3y)1.16
Expense Ratio (net)0.35%
Inception Date2006-06-19
Trade prices are not sourced from all markets
  • Barrons.com12 hours ago

    ETF Flopper: Repeal and Replace Revived, Sinks Health-Care Stocks

    Health-care stocks finished dead last in the Standard & Poor's 500 as Republicans tried yet again to repeal and replace the Affordable Care Act. The Cassidy-Graham bill, named for Senator Bill Cassidy, R-La., and Lindsey Graham, R-S.C., was introduced Sept. 13 and appears to be gaining momentum. Cassidy-Graham would get rid of individual and employer mandates and subsidies and rollback Medicaid, among other things.

  • Market Realist9 days ago

    Introducing Merck’s 2Q17 Immuno-Oncology Blockbuster

    For 2Q17, Keytruda reported revenues of $881 million, which represents 183% growth at constant exchange rates.

  • Market Realist16 days ago

    Eli Lilly’s Cardiovascular Products in 2Q17

    Eli Lilly and Co.’s (LLY) cardiovascular franchise includes two drugs—Cialis and Effient. These drugs comprise ~15.0% of the company's total revenues.